These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2868456

  • 1. Countergradients of nonchemotactic ligands for N-formylmethionylleucylphenylalanine (FMLP) receptors promote FMLP-induced chemotaxis.
    Gray GD, Ohlmann GM.
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):256-62. PubMed ID: 2868456
    [Abstract] [Full Text] [Related]

  • 2. The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.
    Levesque L, Gaudreault RC, Marceau F.
    Can J Physiol Pharmacol; 1991 Mar; 69(3):419-25. PubMed ID: 1647850
    [Abstract] [Full Text] [Related]

  • 3. Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins.
    Gray GD, Smith CW, Hollers JC, Chenoweth DE, Fiegel VD, Nelson RD.
    Antimicrob Agents Chemother; 1983 Nov; 24(5):777-83. PubMed ID: 6318656
    [Abstract] [Full Text] [Related]

  • 4. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
    Stenson WF, Mehta J, Spilberg I.
    Biochem Pharmacol; 1984 Feb 01; 33(3):407-12. PubMed ID: 6142713
    [Abstract] [Full Text] [Related]

  • 5. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD, Elfman F, Lobo E, Sklar L, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1803-12. PubMed ID: 3753993
    [Abstract] [Full Text] [Related]

  • 6. Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues.
    Fabbri E, Spisani S, Barbin L, Biondi C, Buzzi M, Traniello S, Zecchini GP, Ferretti ME.
    Cell Signal; 2000 Jun 01; 12(6):391-8. PubMed ID: 10889468
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Signal transduction in human alveolar macrophages: diminished chemotactic response to FMLP correlates with a diminished density of Gi proteins and FMLP receptors.
    Beaty CD, Martin TR, Wilson CB.
    Am J Respir Cell Mol Biol; 1991 Jul 01; 5(1):87-92. PubMed ID: 1908689
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y, Kanazawa T, Shimamura M, Ueki M, Hazato T.
    Biochem Pharmacol; 1997 Sep 15; 54(6):695-701. PubMed ID: 9310346
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two classes of non-peptide drugs as antagonists of neutrophil receptors for f-Met-Leu-Phe. Pyrazolons and iodinated radiographic contrast agents.
    Levesque L, Gaudreault RC, Marceau F.
    Biochem Pharmacol; 1992 Feb 04; 43(3):553-60. PubMed ID: 1311583
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S, Smith CW.
    Agents Actions; 1989 Mar 04; 26(3-4):372-7. PubMed ID: 2735228
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD, Elfman F, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1813-9. PubMed ID: 3753994
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L, McCall CE, Bass DA, McPhail LC.
    J Immunol; 1987 Nov 01; 139(9):3055-61. PubMed ID: 2822802
    [Abstract] [Full Text] [Related]

  • 15. Effects of non-steroidal anti-inflammatory drugs on isolated human polymorphonuclear leukocytes (PMN): chemotaxis, superoxide production, degranulation and N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) receptor binding.
    Shelly J, Hoff SF.
    Gen Pharmacol; 1989 Nov 01; 20(3):329-34. PubMed ID: 2545509
    [Abstract] [Full Text] [Related]

  • 16. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
    Cavicchioni G, Monesi LG, Ferretti ME, Fabbri E, Rizzuti O, Spisani S.
    Arch Pharm (Weinheim); 1998 Nov 01; 331(11):368-70. PubMed ID: 9881061
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.